期刊簡介預(yù)計(jì)審稿時(shí)間： 約2月

Thoracic Cancer aims to facilitate international collaboration and exchange of comprehensive and cutting-edge information on basic, translational, and applied clinical research in lung cancer, esophageal cancer, mediastinal cancer, breast cancer and other thoracic malignancies. Prevention, treatment and research relevant to Asia-Pacific is a focus area, but submissions from all regions are welcomed. The editors encourage contributions relevant to prevention, general thoracic surgery, medical oncology, radiology, radiation medicine, pathology, basic cancer research, as well as epidemiological and translational studies in thoracic cancer. Thoracic Cancer is the official publication of the Chinese Society of Lung Cancer, International Chinese Society of Thoracic Surgery and is endorsed by the Korean Association for the Study of Lung Cancer and the Hong Kong Cancer Therapy Society.

The Journal publishes a range of article types including: Editorials, Invited Reviews, Mini Reviews, Original Articles, Clinical Guidelines, Technological Notes, Imaging in thoracic cancer, Meeting Reports, Case Reports, Letters to the Editor, Commentaries, and Brief Reports.

《胸腔癌》旨在促進(jìn)肺癌、食道癌、縱隔癌、乳腺癌和其他胸部惡性腫瘤的基礎(chǔ)、轉(zhuǎn)化和應(yīng)用臨床研究方面的國際合作和全面前沿信息的交流。亞太地區(qū)的預(yù)防、治療和研究是重點(diǎn)領(lǐng)域，但歡迎所有地區(qū)的投稿。編輯鼓勵(lì)投稿涉及預(yù)防、普通胸外科、腫瘤內(nèi)科、放射學(xué)、放射醫(yī)學(xué)、病理學(xué)、基礎(chǔ)癌癥研究以及胸腔癌的流行病學(xué)和轉(zhuǎn)化研究。 《胸部腫瘤》是中華醫(yī)學(xué)會肺癌分會、國際華人胸外科學(xué)會的官方刊物，并得到韓國肺癌研究協(xié)會和香港癌癥治療學(xué)會的認(rèn)可。

該期刊發(fā)表多種類型的文章，包括：社論、特邀評論、迷你評論、原創(chuàng)文章、臨床指南、技術(shù)說明、胸部腫瘤影像、會議報(bào)告、病例報(bào)告、致編輯的信、評論和簡要報(bào)告。

《Thoracic Cancer》(胸腺癌)編輯部通訊方式為111 RIVER ST, HOBOKEN, USA, NJ, 07030-5774。如果您需要協(xié)助投稿或潤稿服務(wù)，您可以咨詢我們的客服老師。我們專注于期刊咨詢服務(wù)十年，熟悉發(fā)表政策，可為您提供一對一投稿指導(dǎo)，避免您在投稿時(shí)頻繁碰壁，節(jié)省您的寶貴時(shí)間，有效提升發(fā)表機(jī)率，確保SCI檢索（檢索不了全額退款）。我們視信譽(yù)為生命，多方面確保文章安全保密，在任何情況下都不會泄露您的個(gè)人信息或稿件內(nèi)容。